Go Pro
→ U.K. Royal Air Force officer just cracked America’s biggest economic secret (From Weiss Ratings) (Ad)tc pixel Free WNW Stock Alerts

Meiwu Technology (WNW) Competitors

Meiwu Technology logo
$2.34 -0.05 (-2.09%)
As of 04:00 PM Eastern
Compare

WNW vs. YSG, NAGE, USNA, NATR, and NUS

Should you buy Meiwu Technology stock or one of its competitors? Meiwu Technology's main competitors and comparable companies include Yatsen (YSG), Niagen Bioscience (NAGE), USANA Health Sciences (USNA), Nature's Sunshine Products (NATR), and Nu Skin Enterprises (NUS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "personal care products" industry.

How does Meiwu Technology compare to Yatsen?

Yatsen (NYSE:YSG) and Meiwu Technology (NASDAQ:WNW) are both small-cap consumer staples companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, risk, media sentiment, dividends, institutional ownership and profitability.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Yatsen
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Meiwu Technology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Yatsen has higher revenue and earnings than Meiwu Technology.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Yatsen$614.62M0.40-$11.56M-$0.21N/A
Meiwu Technology$7.08M8.70-$18.59MN/AN/A

Yatsen has a beta of -1.54, suggesting that its share price is 254% less volatile than the broader market. Comparatively, Meiwu Technology has a beta of 0.87, suggesting that its share price is 13% less volatile than the broader market.

Meiwu Technology has a net margin of 0.00% compared to Yatsen's net margin of -4.63%. Meiwu Technology's return on equity of 0.00% beat Yatsen's return on equity.

Company Net Margins Return on Equity Return on Assets
Yatsen-4.63% -7.26% -5.42%
Meiwu Technology N/A N/A N/A

0.3% of Meiwu Technology shares are held by institutional investors. 29.0% of Yatsen shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Yatsen had 8 more articles in the media than Meiwu Technology. MarketBeat recorded 8 mentions for Yatsen and 0 mentions for Meiwu Technology. Yatsen's average media sentiment score of 0.15 beat Meiwu Technology's score of 0.00 indicating that Yatsen is being referred to more favorably in the media.

Company Overall Sentiment
Yatsen Neutral
Meiwu Technology Neutral

Summary

Meiwu Technology beats Yatsen on 6 of the 11 factors compared between the two stocks.

How does Meiwu Technology compare to Niagen Bioscience?

Niagen Bioscience (NASDAQ:NAGE) and Meiwu Technology (NASDAQ:WNW) are both small-cap consumer staples companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, dividends, media sentiment, valuation and risk.

15.4% of Niagen Bioscience shares are held by institutional investors. Comparatively, 0.3% of Meiwu Technology shares are held by institutional investors. 10.0% of Niagen Bioscience shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Niagen Bioscience has higher revenue and earnings than Meiwu Technology.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Niagen Bioscience$129.42M1.95$17.38M$0.1817.61
Meiwu Technology$7.08M8.70-$18.59MN/AN/A

Niagen Bioscience has a beta of 2.09, indicating that its stock price is 109% more volatile than the broader market. Comparatively, Meiwu Technology has a beta of 0.87, indicating that its stock price is 13% less volatile than the broader market.

Niagen Bioscience has a net margin of 12.39% compared to Meiwu Technology's net margin of 0.00%. Niagen Bioscience's return on equity of 17.95% beat Meiwu Technology's return on equity.

Company Net Margins Return on Equity Return on Assets
Niagen Bioscience12.39% 17.95% 13.17%
Meiwu Technology N/A N/A N/A

Niagen Bioscience presently has a consensus target price of $10.33, indicating a potential upside of 225.97%. Given Niagen Bioscience's stronger consensus rating and higher possible upside, research analysts clearly believe Niagen Bioscience is more favorable than Meiwu Technology.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Niagen Bioscience
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
3.00
Meiwu Technology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, Niagen Bioscience had 5 more articles in the media than Meiwu Technology. MarketBeat recorded 5 mentions for Niagen Bioscience and 0 mentions for Meiwu Technology. Niagen Bioscience's average media sentiment score of 0.13 beat Meiwu Technology's score of 0.00 indicating that Niagen Bioscience is being referred to more favorably in the media.

Company Overall Sentiment
Niagen Bioscience Neutral
Meiwu Technology Neutral

Summary

Niagen Bioscience beats Meiwu Technology on 14 of the 15 factors compared between the two stocks.

How does Meiwu Technology compare to USANA Health Sciences?

Meiwu Technology (NASDAQ:WNW) and USANA Health Sciences (NYSE:USNA) are both small-cap consumer staples companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, earnings, valuation, media sentiment, profitability and analyst recommendations.

0.3% of Meiwu Technology shares are held by institutional investors. Comparatively, 54.3% of USANA Health Sciences shares are held by institutional investors. 0.8% of USANA Health Sciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Meiwu Technology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
USANA Health Sciences
2 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Meiwu Technology has a beta of 0.87, indicating that its share price is 13% less volatile than the broader market. Comparatively, USANA Health Sciences has a beta of 0.68, indicating that its share price is 32% less volatile than the broader market.

USANA Health Sciences has higher revenue and earnings than Meiwu Technology.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Meiwu Technology$7.08M8.70-$18.59MN/AN/A
USANA Health Sciences$925.26M0.30$10.76M-$1.21N/A

Meiwu Technology has a net margin of 0.00% compared to USANA Health Sciences' net margin of -2.43%. USANA Health Sciences' return on equity of 3.41% beat Meiwu Technology's return on equity.

Company Net Margins Return on Equity Return on Assets
Meiwu TechnologyN/A N/A N/A
USANA Health Sciences -2.43%3.41%2.50%

In the previous week, USANA Health Sciences had 5 more articles in the media than Meiwu Technology. MarketBeat recorded 5 mentions for USANA Health Sciences and 0 mentions for Meiwu Technology. USANA Health Sciences' average media sentiment score of 1.00 beat Meiwu Technology's score of 0.00 indicating that USANA Health Sciences is being referred to more favorably in the news media.

Company Overall Sentiment
Meiwu Technology Neutral
USANA Health Sciences Positive

Summary

USANA Health Sciences beats Meiwu Technology on 8 of the 11 factors compared between the two stocks.

How does Meiwu Technology compare to Nature's Sunshine Products?

Nature's Sunshine Products (NASDAQ:NATR) and Meiwu Technology (NASDAQ:WNW) are both small-cap consumer staples companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, earnings, profitability and analyst recommendations.

Nature's Sunshine Products has a beta of 0.84, suggesting that its share price is 16% less volatile than the broader market. Comparatively, Meiwu Technology has a beta of 0.87, suggesting that its share price is 13% less volatile than the broader market.

Nature's Sunshine Products currently has a consensus target price of $30.50, suggesting a potential upside of 117.55%. Given Nature's Sunshine Products' stronger consensus rating and higher probable upside, analysts plainly believe Nature's Sunshine Products is more favorable than Meiwu Technology.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nature's Sunshine Products
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67
Meiwu Technology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Nature's Sunshine Products has higher revenue and earnings than Meiwu Technology.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nature's Sunshine Products$480.14M0.51$19.52M$1.0113.88
Meiwu Technology$7.08M8.70-$18.59MN/AN/A

79.4% of Nature's Sunshine Products shares are held by institutional investors. Comparatively, 0.3% of Meiwu Technology shares are held by institutional investors. 3.1% of Nature's Sunshine Products shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Nature's Sunshine Products has a net margin of 3.68% compared to Meiwu Technology's net margin of 0.00%. Nature's Sunshine Products' return on equity of 12.88% beat Meiwu Technology's return on equity.

Company Net Margins Return on Equity Return on Assets
Nature's Sunshine Products3.68% 12.88% 8.17%
Meiwu Technology N/A N/A N/A

In the previous week, Nature's Sunshine Products had 4 more articles in the media than Meiwu Technology. MarketBeat recorded 4 mentions for Nature's Sunshine Products and 0 mentions for Meiwu Technology. Nature's Sunshine Products' average media sentiment score of 1.45 beat Meiwu Technology's score of 0.00 indicating that Nature's Sunshine Products is being referred to more favorably in the media.

Company Overall Sentiment
Nature's Sunshine Products Positive
Meiwu Technology Neutral

Summary

Nature's Sunshine Products beats Meiwu Technology on 12 of the 14 factors compared between the two stocks.

How does Meiwu Technology compare to Nu Skin Enterprises?

Nu Skin Enterprises (NYSE:NUS) and Meiwu Technology (NASDAQ:WNW) are both small-cap consumer staples companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, risk, analyst recommendations, valuation, institutional ownership, profitability and media sentiment.

Nu Skin Enterprises has a beta of 0.97, indicating that its stock price is 3% less volatile than the broader market. Comparatively, Meiwu Technology has a beta of 0.87, indicating that its stock price is 13% less volatile than the broader market.

Nu Skin Enterprises has higher revenue and earnings than Meiwu Technology.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nu Skin Enterprises$1.49B0.16$160.20M-$4.47N/A
Meiwu Technology$7.08M8.70-$18.59MN/AN/A

82.8% of Nu Skin Enterprises shares are held by institutional investors. Comparatively, 0.3% of Meiwu Technology shares are held by institutional investors. 2.8% of Nu Skin Enterprises shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Meiwu Technology has a net margin of 0.00% compared to Nu Skin Enterprises' net margin of -15.73%. Nu Skin Enterprises' return on equity of 6.58% beat Meiwu Technology's return on equity.

Company Net Margins Return on Equity Return on Assets
Nu Skin Enterprises-15.73% 6.58% 3.63%
Meiwu Technology N/A N/A N/A

In the previous week, Nu Skin Enterprises had 1 more articles in the media than Meiwu Technology. MarketBeat recorded 1 mentions for Nu Skin Enterprises and 0 mentions for Meiwu Technology. Nu Skin Enterprises' average media sentiment score of 1.54 beat Meiwu Technology's score of 0.00 indicating that Nu Skin Enterprises is being referred to more favorably in the media.

Company Overall Sentiment
Nu Skin Enterprises Very Positive
Meiwu Technology Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nu Skin Enterprises
2 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Meiwu Technology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Nu Skin Enterprises beats Meiwu Technology on 9 of the 11 factors compared between the two stocks.

Get Meiwu Technology News Delivered to You Automatically

Sign up to receive the latest news and ratings for WNW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WNW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

WNW vs. The Competition

Export
MetricMeiwu TechnologyPersonal Care Products IndustryConsumer Staples SectorNASDAQ Exchange
Market Cap$62.93M$23.47B$15.86B$12.92B
Dividend YieldN/A4.35%3.21%8.90%
P/E RatioN/A19.5413.4225.42
Price / Sales8.7013.17262,949.1795.06
Price / CashN/A26.3857.1552.28
Price / Book0.012.934.596.17
Net Income-$18.59M$1.13B$836.00M$349.50M
7 Day Performance-16.13%-0.63%-0.85%-0.05%
1 Month Performance-6.40%0.40%-0.42%0.80%
1 Year Performance-98.73%-17.71%12.15%15.62%

Meiwu Technology Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
WNW
Meiwu Technology
0.6337 of 5 stars		$2.34
-2.1%		N/A-98.7%$62.93M$7.08MN/A50
YSG
Yatsen
1.0339 of 5 stars		$3.06
+0.7%		N/A-74.3%$287.06M$614.62MN/A1,623
NAGE
Niagen Bioscience
3.6851 of 5 stars		$3.29
flat		$10.33
+214.1%		-67.8%$262.02M$129.42M18.28120
USNA
USANA Health Sciences
2.0484 of 5 stars		$14.06
+0.1%		N/A-54.4%$259.83M$925.26MN/A1,570
NATR
Nature's Sunshine Products
4.2582 of 5 stars		$14.21
flat		$30.50
+114.6%		-19.9%$250.10M$480.14M14.07850

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:WNW) was last updated on 9/4/2026 by MarketBeat.com Staff.
From Our Partners
Trump’s “new Petrodollar” exposed
Trump has reportedly secured control over 65 billion barrels across 17 Venezuelan oil fields, more than the en...
Porter & Company | Sponsoredtc pixel
Musk says UBI is coming. I say it's already here.
Elon Musk says AI could make money irrelevant by 2036. One income program already exists today, funded not by ...
Freedom Financial | Sponsoredtc pixel
Major Buy Alert Issued for September 30th
Keith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...
TradeSmith | Sponsoredtc pixel
Man Who Called SpaceX Rise Says Elon’s NEW Project is Even Bigger
James Altucher called the rise of Nvidia, Apple, and SpaceX years before the crowd. Now he says he has uncover...
Paradigm Press | Sponsoredtc pixel
Half the market is standing on a trapdoor
Nearly half the value of the US stock market now sits in AI stocks - the most concentrated the market has been...
Behind the Markets | Sponsoredtc pixel
Wall Street pays $32K for this type of stock market data. (But see this Labor Day deal now!)
The Bloomberg Terminal costs $32,000 a year and sits on the desks of more than 350,000 Wall Street traders. Mo...
Weiss Ratings | Sponsoredtc pixel
This Overlooked Fund Turns AI Stocks Into Weekly Income
A small fund pays investors weekly income from AI stocks that don't pay dividends on their own. Chief Incom...
Investors Alley | Sponsoredtc pixel
Before Anthropic becomes impossible to ignore...
Riot Platforms just struck a 20-year, 191-megawatt data-center agreement tied to Anthropic, reportedly worth 9...
The Oxford Club | Sponsoredtc pixel